Shortening the time to diagnosis by providing medical guidance by using digital data can support the prediction and prevention of diseases. Timely detection of diseases is one of the biggest challenges in guiding patients to appropriate care, with under-diagnosis and long patient journeys to diagnosis. THE LARGER TREND
The partnership offers a digital solution so that people can be more proactive about preventative healthcare. WHY IT MATTERS
Digital health tools provide personalised insights and actionable medical guidance. People can look for guidance on health issues they may think too insignificant to take to a doctor. The free app provides guidance via an AI chatbot which asks users targeted questions that generate data-driven options and suggestions for the next steps in seeking healthcare.
The app can be downloaded directly, or for people in the US, UK or Germany, and it can be accessed via the Aspirin, Aleve, Midol, Canesten and Iberogast websites. In May, Ada Health clinched a $90 million (€79.7M) Series B round of funding from German pharma giant, Bayer AG. The symptom assessment app currently supports ten languages, but in future, the aim is for a billion people to use the technology. The new funding will help Ada Health expand further into the US.
More than six million people worldwide have used Ada Health, completing over 25 million personal health assessments. The app essentially works like a WhatsApp chat with a trusted family doctor or medical professional, but is available 24/7.
The News Highlights
- IA-based assessment platform Ada Health joins forces with pharmaceutical giant Bayer
- Check the latest Health news updates and information about health.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week